Sheba Medical Center and Enlivex Announce Dosing of the First Patient in Phase I/II Trial Evaluating Allocetra Combined with Chemotherapy in Patients with Peritoneal Metastases Arising from Solid Cancers
Similar Posts
St. Luke’s Goes LIVE with MEDITECH Expanse
Regional healthcare system launches web-based Enterprise Health Record (EHR) for enhanced patient information sharing Focused on putting the patient…
Withings Becomes National Sponsor of Project Power from the American Diabetes Association and Will Distribute Body Comp Smart Scale to Participants
Withings groundbreaking Body Comp Scale helps the American Diabetes Association Project Power participants increase awareness and management of…
GreatCall Inc. Acquires Healthsense
GreatCall Inc., the leader in connected health for active aging, has acquired Healthsense, the leading provider of passive remote…
Zillion Announces Partnership for Cost-Effective, Scalable Digital Health Coaching Solutions
Wellness Corporate Solutions (WCS), an award-winning provider of coaching, biometric screening and customized wellness solutions for private and public-sector…
CancerLinQ and NCCN Collaborating to Provide Evidence-Based, Decision-Making Resources to Physicians
New Collaboration Will Grant CancerLinQ® Subscribers Streamlined Access to the NCCN Compendium® ALEXANDRIA, Va. — CancerLinQ LLC, a wholly owned…